CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Insider Trading for March 2016
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in CHARLES RIVER LABORATORIES INTERNATIONAL, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in CHARLES RIVER LABORATORIES INTERNATIONAL, INC. for March 2016.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 04 2016 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | Chairman, President ... | Option Exercise | M | 59.41 | 20,072 | 1,192,478 | 40,143 | |
Mar 04 2016 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | Chairman, President ... | Sell | S | 75.00 | 20,072 | 1,505,400 | 383,636 | 403.7 K to 383.6 K (-4.97 %) |
Mar 04 2016 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | Chairman, President ... | Buy | M | 59.41 | 20,072 | 1,192,478 | 403,708 | 383.6 K to 403.7 K (+5.23 %) |
Mar 04 2016 | CRL | CHARLES RIVER LABO ... | GILLETT NANCY | Corporate Executive ... | Sell | S | 75.90 | 200 | 15,180 | 11,034 | 11.2 K to 11 K (-1.78 %) |
Mar 04 2016 | CRL | CHARLES RIVER LABO ... | GILLETT NANCY | Corporate Executive ... | Sell | S | 75.83 | 122 | 9,251 | 11,234 | 11.4 K to 11.2 K (-1.07 %) |
Mar 04 2016 | CRL | CHARLES RIVER LABO ... | GILLETT NANCY | Corporate Executive ... | Sell | S | 75.81 | 100 | 7,581 | 11,356 | 11.5 K to 11.4 K (-0.87 %) |
Mar 04 2016 | CRL | CHARLES RIVER LABO ... | GILLETT NANCY | Corporate Executive ... | Sell | S | 75.80 | 100 | 7,580 | 11,456 | 11.6 K to 11.5 K (-0.87 %) |
Mar 04 2016 | CRL | CHARLES RIVER LABO ... | GILLETT NANCY | Corporate Executive ... | Sell | S | 75.79 | 200 | 15,158 | 11,556 | 11.8 K to 11.6 K (-1.70 %) |
Mar 04 2016 | CRL | CHARLES RIVER LABO ... | GILLETT NANCY | Corporate Executive ... | Sell | S | 75.78 | 100 | 7,578 | 11,756 | 11.9 K to 11.8 K (-0.84 %) |
Mar 04 2016 | CRL | CHARLES RIVER LABO ... | GILLETT NANCY | Corporate Executive ... | Sell | S | 75.77 | 100 | 7,577 | 11,856 | 12 K to 11.9 K (-0.84 %) |
Mar 04 2016 | CRL | CHARLES RIVER LABO ... | GILLETT NANCY | Corporate Executive ... | Sell | S | 75.75 | 100 | 7,575 | 11,956 | 12.1 K to 12 K (-0.83 %) |
Mar 04 2016 | CRL | CHARLES RIVER LABO ... | GILLETT NANCY | Corporate Executive ... | Sell | S | 75.73 | 100 | 7,573 | 12,056 | 12.2 K to 12.1 K (-0.82 %) |
Mar 04 2016 | CRL | CHARLES RIVER LABO ... | GILLETT NANCY | Corporate Executive ... | Sell | S | 75.68 | 100 | 7,568 | 12,156 | 12.3 K to 12.2 K (-0.82 %) |
Mar 04 2016 | CRL | CHARLES RIVER LABO ... | GILLETT NANCY | Corporate Executive ... | Sell | S | 75.64 | 100 | 7,564 | 12,256 | 12.4 K to 12.3 K (-0.81 %) |
Mar 04 2016 | CRL | CHARLES RIVER LABO ... | GILLETT NANCY | Corporate Executive ... | Sell | S | 75.61 | 100 | 7,561 | 12,356 | 12.5 K to 12.4 K (-0.80 %) |
Mar 04 2016 | CRL | CHARLES RIVER LABO ... | GILLETT NANCY | Corporate Executive ... | Sell | S | 75.60 | 300 | 22,680 | 12,456 | 12.8 K to 12.5 K (-2.35 %) |
Mar 04 2016 | CRL | CHARLES RIVER LABO ... | GILLETT NANCY | Corporate Executive ... | Sell | S | 75.59 | 100 | 7,559 | 12,756 | 12.9 K to 12.8 K (-0.78 %) |
Mar 04 2016 | CRL | CHARLES RIVER LABO ... | GILLETT NANCY | Corporate Executive ... | Sell | S | 75.58 | 200 | 15,116 | 12,856 | 13.1 K to 12.9 K (-1.53 %) |
Mar 04 2016 | CRL | CHARLES RIVER LABO ... | GILLETT NANCY | Corporate Executive ... | Sell | S | 75.57 | 500 | 37,785 | 13,056 | 13.6 K to 13.1 K (-3.69 %) |
Mar 04 2016 | CRL | CHARLES RIVER LABO ... | GILLETT NANCY | Corporate Executive ... | Sell | S | 75.56 | 100 | 7,556 | 13,556 | 13.7 K to 13.6 K (-0.73 %) |
Mar 04 2016 | CRL | CHARLES RIVER LABO ... | GILLETT NANCY | Corporate Executive ... | Sell | S | 75.55 | 100 | 7,555 | 13,656 | 13.8 K to 13.7 K (-0.73 %) |
Mar 04 2016 | CRL | CHARLES RIVER LABO ... | GILLETT NANCY | Corporate Executive ... | Sell | S | 75.53 | 333 | 25,151 | 13,756 | 14.1 K to 13.8 K (-2.36 %) |
Mar 04 2016 | CRL | CHARLES RIVER LABO ... | GILLETT NANCY | Corporate Executive ... | Sell | S | 75.52 | 67 | 5,060 | 14,089 | 14.2 K to 14.1 K (-0.47 %) |
Mar 04 2016 | CRL | CHARLES RIVER LABO ... | GILLETT NANCY | Corporate Executive ... | Sell | S | 75.50 | 200 | 15,100 | 14,156 | 14.4 K to 14.2 K (-1.39 %) |
Mar 04 2016 | CRL | CHARLES RIVER LABO ... | GILLETT NANCY | Corporate Executive ... | Sell | S | 75.48 | 200 | 15,096 | 14,356 | 14.6 K to 14.4 K (-1.37 %) |
Mar 04 2016 | CRL | CHARLES RIVER LABO ... | GILLETT NANCY | Corporate Executive ... | Sell | S | 75.47 | 300 | 22,641 | 14,556 | 14.9 K to 14.6 K (-2.02 %) |
Mar 04 2016 | CRL | CHARLES RIVER LABO ... | GILLETT NANCY | Corporate Executive ... | Sell | S | 75.46 | 100 | 7,546 | 14,856 | 15 K to 14.9 K (-0.67 %) |
Mar 04 2016 | CRL | CHARLES RIVER LABO ... | GILLETT NANCY | Corporate Executive ... | Sell | S | 75.45 | 200 | 15,090 | 14,956 | 15.2 K to 15 K (-1.32 %) |
Mar 04 2016 | CRL | CHARLES RIVER LABO ... | GILLETT NANCY | Corporate Executive ... | Sell | S | 75.45 | 100 | 7,545 | 15,156 | 15.3 K to 15.2 K (-0.66 %) |
Mar 04 2016 | CRL | CHARLES RIVER LABO ... | GILLETT NANCY | Corporate Executive ... | Sell | S | 75.44 | 300 | 22,632 | 15,256 | 15.6 K to 15.3 K (-1.93 %) |
Mar 04 2016 | CRL | CHARLES RIVER LABO ... | GILLETT NANCY | Corporate Executive ... | Sell | S | 75.43 | 100 | 7,543 | 15,556 | 15.7 K to 15.6 K (-0.64 %) |
Mar 04 2016 | CRL | CHARLES RIVER LABO ... | GILLETT NANCY | Corporate Executive ... | Sell | S | 75.42 | 200 | 15,084 | 15,656 | 15.9 K to 15.7 K (-1.26 %) |
Mar 04 2016 | CRL | CHARLES RIVER LABO ... | GILLETT NANCY | Corporate Executive ... | Sell | S | 75.41 | 100 | 7,541 | 15,856 | 16 K to 15.9 K (-0.63 %) |
Mar 04 2016 | CRL | CHARLES RIVER LABO ... | GILLETT NANCY | Corporate Executive ... | Sell | S | 75.39 | 100 | 7,539 | 15,956 | 16.1 K to 16 K (-0.62 %) |
Mar 04 2016 | CRL | CHARLES RIVER LABO ... | GILLETT NANCY | Corporate Executive ... | Sell | S | 75.38 | 100 | 7,538 | 16,056 | 16.2 K to 16.1 K (-0.62 %) |
Mar 04 2016 | CRL | CHARLES RIVER LABO ... | GILLETT NANCY | Corporate Executive ... | Sell | S | 75.37 | 200 | 15,074 | 16,156 | 16.4 K to 16.2 K (-1.22 %) |
Mar 04 2016 | CRL | CHARLES RIVER LABO ... | GILLETT NANCY | Corporate Executive ... | Sell | S | 75.36 | 300 | 22,608 | 16,356 | 16.7 K to 16.4 K (-1.80 %) |
Mar 04 2016 | CRL | CHARLES RIVER LABO ... | GILLETT NANCY | Corporate Executive ... | Sell | S | 75.35 | 80 | 6,028 | 16,656 | 16.7 K to 16.7 K (-0.48 %) |
Mar 04 2016 | CRL | CHARLES RIVER LABO ... | GILLETT NANCY | Corporate Executive ... | Sell | S | 75.35 | 200 | 15,069 | 16,736 | 16.9 K to 16.7 K (-1.18 %) |
Mar 04 2016 | CRL | CHARLES RIVER LABO ... | GILLETT NANCY | Corporate Executive ... | Sell | S | 75.34 | 420 | 31,643 | 16,936 | 17.4 K to 16.9 K (-2.42 %) |
Mar 04 2016 | CRL | CHARLES RIVER LABO ... | GILLETT NANCY | Corporate Executive ... | Sell | S | 75.33 | 100 | 7,533 | 17,356 | 17.5 K to 17.4 K (-0.57 %) |
Mar 04 2016 | CRL | CHARLES RIVER LABO ... | GILLETT NANCY | Corporate Executive ... | Sell | S | 75.32 | 328 | 24,705 | 17,456 | 17.8 K to 17.5 K (-1.84 %) |
Mar 04 2016 | CRL | CHARLES RIVER LABO ... | GILLETT NANCY | Corporate Executive ... | Sell | S | 75.31 | 600 | 45,186 | 17,784 | 18.4 K to 17.8 K (-3.26 %) |
Mar 04 2016 | CRL | CHARLES RIVER LABO ... | GILLETT NANCY | Corporate Executive ... | Sell | S | 75.30 | 300 | 22,590 | 18,384 | 18.7 K to 18.4 K (-1.61 %) |
Mar 04 2016 | CRL | CHARLES RIVER LABO ... | GILLETT NANCY | Corporate Executive ... | Sell | S | 75.29 | 200 | 15,058 | 18,684 | 18.9 K to 18.7 K (-1.06 %) |
Mar 04 2016 | CRL | CHARLES RIVER LABO ... | GILLETT NANCY | Corporate Executive ... | Sell | S | 75.28 | 300 | 22,584 | 18,884 | 19.2 K to 18.9 K (-1.56 %) |
Mar 04 2016 | CRL | CHARLES RIVER LABO ... | GILLETT NANCY | Corporate Executive ... | Sell | S | 75.27 | 300 | 22,581 | 19,184 | 19.5 K to 19.2 K (-1.54 %) |
Mar 04 2016 | CRL | CHARLES RIVER LABO ... | GILLETT NANCY | Corporate Executive ... | Sell | S | 75.26 | 100 | 7,526 | 19,484 | 19.6 K to 19.5 K (-0.51 %) |
Mar 04 2016 | CRL | CHARLES RIVER LABO ... | GILLETT NANCY | Corporate Executive ... | Sell | S | 75.25 | 100 | 7,525 | 19,584 | 19.7 K to 19.6 K (-0.51 %) |
Mar 04 2016 | CRL | CHARLES RIVER LABO ... | GILLETT NANCY | Corporate Executive ... | Sell | S | 75.24 | 500 | 37,620 | 19,684 | 20.2 K to 19.7 K (-2.48 %) |
Mar 04 2016 | CRL | CHARLES RIVER LABO ... | GILLETT NANCY | Corporate Executive ... | Sell | S | 75.23 | 500 | 37,615 | 20,184 | 20.7 K to 20.2 K (-2.42 %) |
Mar 04 2016 | CRL | CHARLES RIVER LABO ... | GILLETT NANCY | Corporate Executive ... | Sell | S | 75.23 | 100 | 7,523 | 20,684 | 20.8 K to 20.7 K (-0.48 %) |
Mar 04 2016 | CRL | CHARLES RIVER LABO ... | GILLETT NANCY | Corporate Executive ... | Sell | S | 75.22 | 600 | 45,132 | 20,784 | 21.4 K to 20.8 K (-2.81 %) |
Mar 04 2016 | CRL | CHARLES RIVER LABO ... | GILLETT NANCY | Corporate Executive ... | Sell | S | 75.21 | 600 | 45,126 | 21,384 | 22 K to 21.4 K (-2.73 %) |
Mar 04 2016 | CRL | CHARLES RIVER LABO ... | GILLETT NANCY | Corporate Executive ... | Sell | S | 75.20 | 400 | 30,080 | 21,984 | 22.4 K to 22 K (-1.79 %) |
Mar 04 2016 | CRL | CHARLES RIVER LABO ... | GILLETT NANCY | Corporate Executive ... | Sell | S | 75.19 | 700 | 52,633 | 22,384 | 23.1 K to 22.4 K (-3.03 %) |
Mar 04 2016 | CRL | CHARLES RIVER LABO ... | GILLETT NANCY | Corporate Executive ... | Sell | S | 75.18 | 600 | 45,108 | 23,084 | 23.7 K to 23.1 K (-2.53 %) |
Mar 04 2016 | CRL | CHARLES RIVER LABO ... | GILLETT NANCY | Corporate Executive ... | Sell | S | 75.17 | 200 | 15,034 | 23,684 | 23.9 K to 23.7 K (-0.84 %) |
Mar 04 2016 | CRL | CHARLES RIVER LABO ... | GILLETT NANCY | Corporate Executive ... | Sell | S | 75.17 | 100 | 7,517 | 23,884 | 24 K to 23.9 K (-0.42 %) |
Mar 04 2016 | CRL | CHARLES RIVER LABO ... | GILLETT NANCY | Corporate Executive ... | Sell | S | 75.16 | 300 | 22,548 | 23,984 | 24.3 K to 24 K (-1.24 %) |
Mar 04 2016 | CRL | CHARLES RIVER LABO ... | GILLETT NANCY | Corporate Executive ... | Sell | S | 75.16 | 100 | 7,516 | 24,284 | 24.4 K to 24.3 K (-0.41 %) |
Mar 04 2016 | CRL | CHARLES RIVER LABO ... | GILLETT NANCY | Corporate Executive ... | Sell | S | 75.15 | 400 | 30,060 | 24,384 | 24.8 K to 24.4 K (-1.61 %) |
Mar 04 2016 | CRL | CHARLES RIVER LABO ... | GILLETT NANCY | Corporate Executive ... | Sell | S | 75.14 | 500 | 37,570 | 24,784 | 25.3 K to 24.8 K (-1.98 %) |
Mar 04 2016 | CRL | CHARLES RIVER LABO ... | GILLETT NANCY | Corporate Executive ... | Sell | S | 75.14 | 300 | 22,541 | 25,284 | 25.6 K to 25.3 K (-1.17 %) |
Mar 04 2016 | CRL | CHARLES RIVER LABO ... | GILLETT NANCY | Corporate Executive ... | Sell | S | 75.13 | 400 | 30,052 | 25,584 | 26 K to 25.6 K (-1.54 %) |
Mar 04 2016 | CRL | CHARLES RIVER LABO ... | GILLETT NANCY | Corporate Executive ... | Sell | S | 75.13 | 100 | 7,513 | 25,984 | 26.1 K to 26 K (-0.38 %) |
Mar 04 2016 | CRL | CHARLES RIVER LABO ... | GILLETT NANCY | Corporate Executive ... | Sell | S | 75.12 | 327 | 24,564 | 26,084 | 26.4 K to 26.1 K (-1.24 %) |
Mar 04 2016 | CRL | CHARLES RIVER LABO ... | GILLETT NANCY | Corporate Executive ... | Sell | S | 75.11 | 200 | 15,022 | 26,411 | 26.6 K to 26.4 K (-0.75 %) |
Mar 04 2016 | CRL | CHARLES RIVER LABO ... | GILLETT NANCY | Corporate Executive ... | Sell | S | 75.11 | 100 | 7,511 | 26,611 | 26.7 K to 26.6 K (-0.37 %) |
Mar 04 2016 | CRL | CHARLES RIVER LABO ... | GILLETT NANCY | Corporate Executive ... | Option Exercise | M | 36.25 | 5,538 | 200,753 | 0 | |
Mar 04 2016 | CRL | CHARLES RIVER LABO ... | GILLETT NANCY | Corporate Executive ... | Option Exercise | M | 59.41 | 4,379 | 260,156 | 8,759 | |
Mar 04 2016 | CRL | CHARLES RIVER LABO ... | GILLETT NANCY | Corporate Executive ... | Option Exercise | M | 40.40 | 5,502 | 222,281 | 5,502 | |
Mar 04 2016 | CRL | CHARLES RIVER LABO ... | GILLETT NANCY | Corporate Executive ... | Sell | S | 75.10 | 500 | 37,550 | 26,711 | 27.2 K to 26.7 K (-1.84 %) |
Mar 04 2016 | CRL | CHARLES RIVER LABO ... | GILLETT NANCY | Corporate Executive ... | Sell | S | 75.08 | 600 | 45,048 | 27,211 | 27.8 K to 27.2 K (-2.16 %) |
Mar 04 2016 | CRL | CHARLES RIVER LABO ... | GILLETT NANCY | Corporate Executive ... | Sell | S | 75.07 | 300 | 22,521 | 27,811 | 28.1 K to 27.8 K (-1.07 %) |
Mar 04 2016 | CRL | CHARLES RIVER LABO ... | GILLETT NANCY | Corporate Executive ... | Sell | S | 75.07 | 100 | 7,507 | 28,111 | 28.2 K to 28.1 K (-0.35 %) |
Mar 04 2016 | CRL | CHARLES RIVER LABO ... | GILLETT NANCY | Corporate Executive ... | Sell | S | 75.06 | 400 | 30,024 | 28,211 | 28.6 K to 28.2 K (-1.40 %) |
Mar 04 2016 | CRL | CHARLES RIVER LABO ... | GILLETT NANCY | Corporate Executive ... | Sell | S | 75.05 | 600 | 45,030 | 28,611 | 29.2 K to 28.6 K (-2.05 %) |
Mar 04 2016 | CRL | CHARLES RIVER LABO ... | GILLETT NANCY | Corporate Executive ... | Sell | S | 75.04 | 500 | 37,520 | 29,211 | 29.7 K to 29.2 K (-1.68 %) |
Mar 04 2016 | CRL | CHARLES RIVER LABO ... | GILLETT NANCY | Corporate Executive ... | Sell | S | 75.03 | 100 | 7,503 | 29,711 | 29.8 K to 29.7 K (-0.34 %) |
Mar 04 2016 | CRL | CHARLES RIVER LABO ... | GILLETT NANCY | Corporate Executive ... | Sell | S | 75.02 | 300 | 22,506 | 29,811 | 30.1 K to 29.8 K (-1.00 %) |
Mar 04 2016 | CRL | CHARLES RIVER LABO ... | GILLETT NANCY | Corporate Executive ... | Sell | S | 75.01 | 104 | 7,801 | 30,111 | 30.2 K to 30.1 K (-0.34 %) |
Mar 04 2016 | CRL | CHARLES RIVER LABO ... | GILLETT NANCY | Corporate Executive ... | Sell | S | 75.00 | 300 | 22,500 | 30,215 | 30.5 K to 30.2 K (-0.98 %) |
Mar 04 2016 | CRL | CHARLES RIVER LABO ... | GILLETT NANCY | Corporate Executive ... | Sell | S | 75.00 | 11 | 825 | 30,515 | 30.5 K to 30.5 K (-0.04 %) |
Mar 04 2016 | CRL | CHARLES RIVER LABO ... | GILLETT NANCY | Corporate Executive ... | Sell | S | 74.99 | 400 | 29,996 | 30,526 | 30.9 K to 30.5 K (-1.29 %) |
Mar 04 2016 | CRL | CHARLES RIVER LABO ... | GILLETT NANCY | Corporate Executive ... | Sell | S | 74.98 | 400 | 29,992 | 30,926 | 31.3 K to 30.9 K (-1.28 %) |
Mar 04 2016 | CRL | CHARLES RIVER LABO ... | GILLETT NANCY | Corporate Executive ... | Sell | S | 74.98 | 100 | 7,498 | 31,326 | 31.4 K to 31.3 K (-0.32 %) |
Mar 04 2016 | CRL | CHARLES RIVER LABO ... | GILLETT NANCY | Corporate Executive ... | Sell | S | 74.97 | 100 | 7,497 | 31,426 | 31.5 K to 31.4 K (-0.32 %) |
Mar 04 2016 | CRL | CHARLES RIVER LABO ... | GILLETT NANCY | Corporate Executive ... | Sell | S | 74.97 | 100 | 7,497 | 31,526 | 31.6 K to 31.5 K (-0.32 %) |
Mar 04 2016 | CRL | CHARLES RIVER LABO ... | GILLETT NANCY | Corporate Executive ... | Sell | S | 74.96 | 149 | 11,169 | 31,626 | 31.8 K to 31.6 K (-0.47 %) |
Mar 04 2016 | CRL | CHARLES RIVER LABO ... | GILLETT NANCY | Corporate Executive ... | Sell | S | 74.96 | 251 | 18,814 | 31,775 | 32 K to 31.8 K (-0.78 %) |
Mar 04 2016 | CRL | CHARLES RIVER LABO ... | GILLETT NANCY | Corporate Executive ... | Sell | S | 74.95 | 100 | 7,495 | 32,026 | 32.1 K to 32 K (-0.31 %) |
Mar 04 2016 | CRL | CHARLES RIVER LABO ... | GILLETT NANCY | Corporate Executive ... | Sell | S | 74.95 | 100 | 7,495 | 32,126 | 32.2 K to 32.1 K (-0.31 %) |
Mar 04 2016 | CRL | CHARLES RIVER LABO ... | GILLETT NANCY | Corporate Executive ... | Sell | S | 74.93 | 100 | 7,493 | 32,226 | 32.3 K to 32.2 K (-0.31 %) |
Mar 04 2016 | CRL | CHARLES RIVER LABO ... | GILLETT NANCY | Corporate Executive ... | Sell | S | 74.92 | 200 | 14,984 | 32,326 | 32.5 K to 32.3 K (-0.61 %) |
Mar 04 2016 | CRL | CHARLES RIVER LABO ... | GILLETT NANCY | Corporate Executive ... | Sell | S | 74.91 | 100 | 7,491 | 32,526 | 32.6 K to 32.5 K (-0.31 %) |
Mar 04 2016 | CRL | CHARLES RIVER LABO ... | GILLETT NANCY | Corporate Executive ... | Sell | S | 74.89 | 600 | 44,934 | 32,626 | 33.2 K to 32.6 K (-1.81 %) |
Mar 04 2016 | CRL | CHARLES RIVER LABO ... | GILLETT NANCY | Corporate Executive ... | Sell | S | 74.88 | 400 | 29,952 | 33,226 | 33.6 K to 33.2 K (-1.19 %) |
Mar 04 2016 | CRL | CHARLES RIVER LABO ... | GILLETT NANCY | Corporate Executive ... | Sell | S | 74.86 | 100 | 7,486 | 33,626 | 33.7 K to 33.6 K (-0.30 %) |
Mar 04 2016 | CRL | CHARLES RIVER LABO ... | GILLETT NANCY | Corporate Executive ... | Buy | M | 36.25 | 5,538 | 200,753 | 33,726 | 28.2 K to 33.7 K (+19.65 %) |
Mar 04 2016 | CRL | CHARLES RIVER LABO ... | GILLETT NANCY | Corporate Executive ... | Buy | M | 59.41 | 4,379 | 260,156 | 28,188 | 23.8 K to 28.2 K (+18.39 %) |
Mar 04 2016 | CRL | CHARLES RIVER LABO ... | GILLETT NANCY | Corporate Executive ... | Buy | M | 40.40 | 5,502 | 222,281 | 23,809 | 18.3 K to 23.8 K (+30.05 %) |
Mar 01 2016 | CRL | CHARLES RIVER LABO ... | Crowley John J | SVP, Chief Accounti ... | Option Exercise | A | 73.70 | 5,360 | 395,032 | 5,360 | |
Mar 01 2016 | CRL | CHARLES RIVER LABO ... | Crowley John J | SVP, Chief Accounti ... | Payment of Exercise | F | 73.70 | 76 | 5,601 | 5,883 | 6 K to 5.9 K (-1.28 %) |
Mar 01 2016 | CRL | CHARLES RIVER LABO ... | Crowley John J | SVP, Chief Accounti ... | Payment of Exercise | F | 73.70 | 68 | 5,012 | 5,959 | 6 K to 6 K (-1.13 %) |
Mar 01 2016 | CRL | CHARLES RIVER LABO ... | Crowley John J | SVP, Chief Accounti ... | Grant | A | 0.00 | 1,093 | 0 | 6,027 | 4.9 K to 6 K (+22.15 %) |
Mar 01 2016 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Payment of Exercise | F | 73.70 | 3,943 | 290,599 | 111,346 | 115.3 K to 111.3 K (-3.42 %) | |
Mar 01 2016 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Grant | A | 0.00 | 8,380 | 0 | 115,289 | 106.9 K to 115.3 K (+7.84 %) | |
Mar 01 2016 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Payment of Exercise | F | 73.70 | 523 | 38,545 | 106,909 | 107.4 K to 106.9 K (-0.49 %) | |
Mar 01 2016 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Payment of Exercise | F | 73.70 | 1,315 | 96,916 | 107,432 | 108.7 K to 107.4 K (-1.21 %) | |
Mar 01 2016 | CRL | CHARLES RIVER LABO ... | Molho Davide | Corporate Executive ... | Option Exercise | A | 73.70 | 33,498 | 2,468,803 | 33,498 | |
Mar 01 2016 | CRL | CHARLES RIVER LABO ... | Molho Davide | Corporate Executive ... | Payment of Exercise | F | 73.70 | 654 | 48,200 | 59,345 | 60 K to 59.3 K (-1.09 %) |
Mar 01 2016 | CRL | CHARLES RIVER LABO ... | Molho Davide | Corporate Executive ... | Payment of Exercise | F | 73.70 | 658 | 48,495 | 59,999 | 60.7 K to 60 K (-1.08 %) |
Mar 01 2016 | CRL | CHARLES RIVER LABO ... | Molho Davide | Corporate Executive ... | Grant | A | 0.00 | 6,826 | 0 | 60,657 | 53.8 K to 60.7 K (+12.68 %) |
Mar 01 2016 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | Chairman, President ... | Option Exercise | A | 73.70 | 100,494 | 7,406,408 | 100,494 | |
Mar 01 2016 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | Chairman, President ... | Payment of Exercise | F | 73.70 | 2,397 | 176,659 | 383,636 | 386 K to 383.6 K (-0.62 %) |
Mar 01 2016 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | Chairman, President ... | Payment of Exercise | F | 73.70 | 2,301 | 169,584 | 386,033 | 388.3 K to 386 K (-0.59 %) |
Mar 01 2016 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | Chairman, President ... | Grant | A | 0.00 | 20,478 | 0 | 388,334 | 367.9 K to 388.3 K (+5.57 %) |
Mar 01 2016 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Option Exercise | A | 73.70 | 16,749 | 1,234,401 | 16,749 | |
Mar 01 2016 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Payment of Exercise | F | 73.70 | 159 | 11,718 | 10,791 | 11 K to 10.8 K (-1.45 %) |
Mar 01 2016 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Grant | A | 0.00 | 3,413 | 0 | 10,950 | 7.5 K to 11 K (+45.28 %) |